Area of focus

Regulatory Exclusivities, Hatch-Waxman, and Similar Statutes

Blog Post

FDA’s Bendeka decision reverses approvals of Treanda generics

Yesterday, FDA released a letter stating how the agency intends to implement the scope of orphan drug exclusivity awarded to Eagle Pharmaceuticals’ Bendeka (bendamustine HCl) by the...

Quick view Full view
Loading data